FMO5 and metabolic dysfunction-associated steatotic liver disease: The role of folate in MASLD remains unclear, but has been linked to hyperhomocysteinemia [45], choline metabolism [46], AMPK pathway activation [47], and NADPH oxidase synthesis [48].